Literature DB >> 17631234

HIV infection in older adults.

Vera P Luther1, Aimee M Wilkin.   

Abstract

The incidence and prevalence of HIV infection in older adults is rising, with disproportionate increases in women and minorities. Compared with younger adults, older patients who have HIV often are diagnosed later in the course of the disease and may have an accelerated decline in immune function. Although the prognosis for older adults has improved with the initiation of highly active antiretroviral therapy, there remains a higher risk for comorbid illness. Additional efforts to diagnose and prevent HIV infection in this older age group are necessary to decrease the transmission of HIV and to reduce the morbidity and mortality associated with this infection.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17631234     DOI: 10.1016/j.cger.2007.02.004

Source DB:  PubMed          Journal:  Clin Geriatr Med        ISSN: 0749-0690            Impact factor:   3.076


  48 in total

Review 1.  What do we know about older adults and HIV? A review of social and behavioral literature.

Authors:  Andrea Sankar; Andrea Nevedal; Stewart Neufeld; Rico Berry; Mark Luborsky
Journal:  AIDS Care       Date:  2011-06-14

2.  Vitamin D deficiency in HIV-infected postmenopausal Hispanic and African-American women.

Authors:  E M Stein; M T Yin; D J McMahon; A Shu; C A Zhang; D C Ferris; I Colon; J F Dobkin; S M Hammer; E Shane
Journal:  Osteoporos Int       Date:  2010-06-29       Impact factor: 4.507

3.  Risk-based HIV testing in South Carolina health care settings failed to identify the majority of infected individuals.

Authors:  Wayne A Duffus; Kristina Weis; Lynda Kettinger; Terri Stephens; Helmut Albrecht; James J Gibson
Journal:  AIDS Patient Care STDS       Date:  2009-05       Impact factor: 5.078

Review 4.  Drug interactions and antiretroviral drug monitoring.

Authors:  Matthew Foy; C John Sperati; Gregory M Lucas; Michelle M Estrella
Journal:  Curr HIV/AIDS Rep       Date:  2014-09       Impact factor: 5.071

5.  Age, comorbidities, and AIDS predict a frailty phenotype in men who have sex with men.

Authors:  Keri N Althoff; Lisa P Jacobson; Ross D Cranston; Roger Detels; John P Phair; Xiuhong Li; Joseph B Margolick
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2013-10-14       Impact factor: 6.053

6.  Relationship between poor physical function, inflammatory markers, and comorbidities in HIV-infected women on antiretroviral therapy.

Authors:  Amy S Baranoski; Ariana Harris; Daniel Michaels; Renee Miciek; Thomas Storer; Paola Sebastiani; Monty Montano
Journal:  J Womens Health (Larchmt)       Date:  2013-11-12       Impact factor: 2.681

7.  HIV infection and the risk of acute myocardial infarction.

Authors:  Matthew S Freiberg; Chung-Chou H Chang; Lewis H Kuller; Melissa Skanderson; Elliott Lowy; Kevin L Kraemer; Adeel A Butt; Matthew Bidwell Goetz; David Leaf; Kris Ann Oursler; David Rimland; Maria Rodriguez Barradas; Sheldon Brown; Cynthia Gibert; Kathy McGinnis; Kristina Crothers; Jason Sico; Heidi Crane; Alberta Warner; Stephen Gottlieb; John Gottdiener; Russell P Tracy; Matthew Budoff; Courtney Watson; Kaku A Armah; Donna Doebler; Kendall Bryant; Amy C Justice
Journal:  JAMA Intern Med       Date:  2013-04-22       Impact factor: 21.873

8.  Low bone mass and high bone turnover in postmenopausal human immunodeficiency virus-infected women.

Authors:  Michael T Yin; Don J McMahon; David C Ferris; Chiyuan A Zhang; Aimee Shu; Ronald Staron; Ivelisse Colon; Jeffrey Laurence; Jay F Dobkin; Scott M Hammer; Elizabeth Shane
Journal:  J Clin Endocrinol Metab       Date:  2009-12-04       Impact factor: 5.958

9.  Aging exacerbates extrapyramidal motor signs in the era of highly active antiretroviral therapy.

Authors:  Victor Valcour; Michael R Watters; Andrew E Williams; Ned Sacktor; Aaron McMurtray; Cecilia Shikuma
Journal:  J Neurovirol       Date:  2008-11-12       Impact factor: 2.643

Review 10.  Aging of the human innate immune system in HIV infection.

Authors:  Heidi J Zapata; Albert C Shaw
Journal:  Curr Opin Immunol       Date:  2014-07-02       Impact factor: 7.486

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.